Complete Report is Available @ http://www.sandlerresearch.org/global-pcos-drugs-market-2014-2018.html . This report covers the present scenario and the growth prospects of the Global PCOS Drugs market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of marketed, off-label, and generic drugs used in the treatment of PCOS.

1. Global PCOS Drugs Market 2014-2018
Order this report by calling
+1 888 391 5441 or Send an email
to sales@sandlerresearch.org
with your contact details and
questions if any.
1© SandlerResearch.org/ Contact sales@sandlerresearch.org
Published: April 2014
Single User PDF: US$ 2500
Corporate User PDF: US$ 3500

2. Global PCOS Drugs Market 2014-2018
PCOS, also known as Stein-Leventhal Syndrome, is one of the most common hormonal
endocrine disorders in women. It is characterized by polycystic ovaries, irregular or no
menstrual periods, irregular ovulation, and high levels of androgens (male hormones) in
the body.
The exact cause of PCOS is unknown. In PCOS, small cysts form on the ovaries, which do
not produce a sufficient amount of hormone to initiate ovulation.
The ovarian follicles, which are filled with fluid in preparation for ovulation, remain as
cysts when ovulation does not occur.
Lifestyle modifications, medication, and surgery are some of the currently available
treatments for PCOS.
Analysts forecast the Global PCOS Drugs market will grow at a CAGR of 2.65 percent over
the period 2013-2018.
2© SandlerResearch.org/ Contact sales@sandlerresearch.org
Reach us at
+ 1 888 391 5441 | sales@sandlerresearch.org

3. Global PCOS Drugs Market 2014-2018
Covered in this Report
This report covers the present scenario and the growth prospects of the Global PCOS
Drugs market for the period 2014-2018.
To calculate the market size, the report considers the revenue generated through the
sales of marketed, off-label, and generic drugs used in the treatment of PCOS.
The Global PCOS Drugs Market 2014-2018, has been prepared based on an in-depth
market analysis with inputs from industry experts.
The report covers the Americas and the EMEA and APAC regions; it also covers the Global
PCOS Drugs market landscape and its growth prospects in the coming years. The report
also includes a discussion of the key vendors operating in this market.
3© SandlerResearch.org/ Contact sales@sandlerresearch.org
Complete Report is Available @
http://www.sandlerresearch.org/global-pcos-drugs-market-2014-2018.html .

4. Global PCOS Drugs Market 2014-2018
Key Regions
Americas
EMEA
APAC
Key Vendors
Bristol Myers Squibb Co.
Merck & Co. Inc.
Novartis AG
Sanofi SA
Teva Pharmaceutical Inc.
4© SandlerResearch.org/ Contact sales@sandlerresearch.org
Inquire Before buying the Report @
http://www.sandlerresearch.org/inquire-before-buying?rname=16794 .

5. Global PCOS Drugs Market 2014-2018
Other Prominent Vendors
AstraZeneca plc
Catalysis SL
Crinetics Pharmaceuticals Inc.
Dexa Medica Group
EffRx Inc.
Neurocrine Biosciences Inc.
Market Driver
Increase in Patient Population.
Market Challenge
Lack of Approved Drugs.
Market Trend
Increase in Awareness of PCOS Drugs.
5© SandlerResearch.org/ Contact sales@sandlerresearch.org
Get discount on the Report @
http://www.sandlerresearch.org/discount?rname=16794 .

6. Global PCOS Drugs Market 2014-2018
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
6© SandlerResearch.org/ Contact sales@sandlerresearch.org
Browse All Reports on
Pharmaceutical Market, Therapeutics Market